18.10.2017
- As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...
07.09.2017
- Novartis CEO Joseph Jimenez has announced he will leave the Swiss-based drugnaker in early 2018, after eight years at the helm, and return to his native US. However, he will remain...
19.07.2017
- UK biopharma Oxford BioMedica has signed another major deal with Swiss drugmaker Novartis to supply lentiviral vectors used to create novel cell therapeutics, including CTL019...
25.05.2017
- Novartis has signed a Memorandum of Understanding (MoU) with Pakistan’s Ministry of National Health Services, Regulations and Coordination to increase access to treatment for poor...
15.05.2017
- Swiss pharma company Novartis has exercised an option that gives it global development and commercialization rights to a drug being developed by US biotech Conatus Pharmaceuticals...
08.05.2017
- Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
26.04.2017
- The chemical industry is the most important supplier of the pharmaceutical industry, but it can´t keep pace with the economic strength and R&D intensity of pharma. This underlines...
